SNU-C2AHomo sapiens (Human)Cancer cell line

Also known as: C2A, NCI-SNU-C2A, SNUC2A, SUN-C2A (Occasionally.)

🤖 AI SummaryBased on 7 publications

Quick Overview

Human colorectal cancer cell line with known mutations and drug sensitivity profiles.

Detailed Summary

SNU-C2A is a human colorectal cancer cell line derived from a patient with colorectal cancer. It is widely used in cancer research to study molecular mechanisms, drug responses, and genetic mutations associated with cancer progression. The cell line has been characterized for its genetic profile, including mutations in key oncogenes and tumor suppressor genes, which contribute to its tumorigenic potential. SNU-C2A is also utilized in studies investigating the efficacy of targeted therapies and chemotherapeutic agents, providing insights into potential treatment strategies for colorectal cancer. Its availability in various research databases makes it a valuable resource for preclinical studies.
Generated on 6/17/2025

Basic Information

Database IDCVCL_1709
SpeciesHomo sapiens (Human)
Tissue SourceCecum[UBERON:UBERON_0001153]

Donor Information

Age43
Age CategoryAdult
SexFemale
Raceasian
Subtype FeaturesMSI

Disease Information

DiseaseCecum adenocarcinoma
LineageBowel
SubtypeColon Adenocarcinoma
OncoTree CodeCOAD

DepMap Information

Source TypeATCC
Source IDACH-000967_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Arg273His (c.818G>A)Homozygous-Unknown, PubMed=16264262
MutationSimpleTP53p.Arg273Cys (c.817C>T)Homozygous-PubMed=35933914
MutationSimpleKRASp.Gly12Asp (c.35G>A)Unspecified-PubMed=29786757

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11,14
D13S317
9,12
D16S539
8,9
D18S51
15,16
D19S433
12
D21S11
29
D2S1338
18
D3S1358
13
D5S818
8,9
D7S820
13,16
D8S1179
11,13
FGA
20,22
Penta D
10
Penta E
12,19
TH01
9
TPOX
8
vWA
15,19
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.

Golub T.R., Root D.E., Hahn W.C.

Sci. Data 1:140035-140035(2014).

The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets.

Linnebacher M., Cordero F., Di Nicolantonio F., Bardelli A.

Nat. Commun. 6:7002.1-7002.10(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Biology of SNU cell lines.";

Ku J.-L., Park J.-G.

Cancer Res. Treat. 37:1-19(2005).

Mutations in hMSH6 alone are not sufficient to cause the microsatellite instability in colorectal cancer cell lines.

Ku J.-L., Yoon K.-A., Kim D.-Y., Park J.-G.

Eur. J. Cancer 35:1724-1729(1999).

Biology of colorectal and gastric cancer cell lines.";

Park J.-G., Gazdar A.F.

J. Cell. Biochem. Suppl. 24:131-141(1996).

Characteristics of cell lines established from human colorectal carcinoma.

Johnson B.E., Gazdar A.F.

Cancer Res. 47:6710-6718(1987).